During the past decade, SingHealth Investigational Medicine Unit conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SingHealth Investigational Medicine Unit" #1 sponsor was "Singapore General Hospital" with 4 trials, followed by "Tychan Pte Ltd." with 3 trials sponsored, "Arcturus Therapeutics, Inc." with 2 trials sponsored, "National University of Singapore" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SingHealth Investigational Medicine Unit" #1 collaborator was "Duke-NUS Graduate Medical School" with 6 trials as a collaborator, "Singapore Clinical Research Institute" with 2 trials as a collaborator, "60 Degrees Pharmaceuticals LLC" with 1 trials as a collaborator, "National University Health System, Singapore" with 1 trials as a collaborator and "National University Hospital, Singapore" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "SingHealth Investigational Medicine Unit" are "Yellow Fever" (3 trials), "Rabies" (2 trials), "SARS-CoV-2" (2 trials), "Treatment of Acute Zika Virus Infection" (2 trials) and "Calcium Metabolism" (1 trials). Many other conditions were trialed in "SingHealth Investigational Medicine Unit" in a lesser frequency.

Most popular intervention types in "SingHealth Investigational Medicine Unit" are "Biological" (8 trials), "Drug" (6 trials), "Other" (5 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "0.9% Saline" (2 trials), "PIKA rabies vaccine" (2 trials), "RABIPUR®" (2 trials) and "Tyzivumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "SingHealth Investigational Medicine Unit" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SingHealth Investigational Medicine Unit". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in SingHealth Investigational Medicine Unit, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in SingHealth Investigational Medicine Unit, 8 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".